IP Library Granted Patent US 9,459,210
Granted Patent B2
US 9,459,210 · App. 13/884,721 · Granted Oct 4, 2016

Static magnetic field induced differential fluorescence emission

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,459,210
App. No.
13/884,721
Granted
Oct 4, 2016
Kind
B2
Abstract

Exposure to a static magnetic field changes the fluorescence intensity of a wide range of fluorophores, including small molecules (e.g., tryptophan), complex organizations of fluorophores (e.g., proteins), quantum dots, nanoparticles, and other materials. Different materials may experience different changes in fluorescence emission upon exposure to a magnetic field—for instance, some or all of a material's fluorescence emission spectrum may increase in amplitude or shift in wavelength. Different materials may also experience different changes in relaxation time, which is the time constant associated with fluorescence decay. These magnetically induced differences fluorescence emission spectra and decay can be used to identify, classify, or sort materials noninvasively.

Claims (43)

1. A method of discriminating a fluorescent region of a sample, the method comprising:

determining a first relaxation time associated with a decay of the fluorescence of at least part of the fluorescent region in the absence of a magnetic field;

determining a second relaxation time associated with a decay of the fluorescence of the at least part of the fluorescent region in the presence of the magnetic field;

performing a comparison of the first relaxation time to the second relaxation time to determine a difference between the first relaxation time and the second relaxation time; and

identifying the at least part of the fluorescent region based on the comparison of the first relaxation time to the second relaxation time and the difference between the first relaxation time and the second relaxation time.

2. The method of claim 1 , wherein the sample comprises at least one of a biological sample, a tissue, a cell, a particle, a protein, and a particle tagged with a fluorophore.

3. The method of claim 1 , further comprising setting a strength of the magnetic field to be about 35 mT to about 100 mT.

4. The method of claim 1 , wherein determining the first relaxation time comprises obtaining a first series of images of the at least part of the fluorescent region, and wherein determining the second relaxation time comprises obtaining a second series of images of the at least part of the fluorescent region.

5. The method of claim 4 , further comprising:

determining a change in a first fluorescence spectrum associated with the at least part of the fluorescent region from the first series of images;

determining a change in a second fluorescence spectrum associated with the at least part of the fluorescent region from the second series of images; and

wherein performing the comparison of the first relaxation time to the second relaxation time comprises comparing the change in the first fluorescence spectrum to the change in the second fluorescence spectrum.

6. The method of claim 1 , wherein the first relaxation time corresponds to a relaxation associated with at least one process that is not affected by the magnetic field.

7. The method of claim 1 , further comprising:

discriminating between the at least part of the fluorescent region and another part of the fluorescent region based on the comparison of the first relaxation time to the second relaxation time.

8. The method of claim 1 , further comprising:

determining a change in an emission wavelength of the fluorescent region in the presence of the magnetic field.

9. The method of claim 1 , further comprising:

applying the magnetic field to the sample; and

withdrawing the magnetic field to create the absence of the magnetic field.

10. The method of claim 1 , wherein identifying the at least part of the fluorescent region comprises identifying at least one of a quantum dot, an organic molecule, an aromatic amino acid, a protein, or another fluorescent material.

11. The method of claim 1 , further comprising applying the magnetic field to the fluorescent region, wherein applying the magnetic field comprises orienting a magnetic field vector associated with the magnetic field perpendicular to an electric field vector associated with an electromagnetic field used to induce fluorescence of the fluorescent region.

12. The method of claim 11 , wherein applying the magnetic field comprises varying an orientation of a magnetic field vector associated with the magnetic field.

13. The method of claim 12 , further comprising:

measuring a change in the fluorescence as a function of the orientation of the magnetic field vector; and

identifying the at least part of the fluorescent region based on the change in the fluorescence.

14. The method of claim 1 , wherein at least part of the fluorescent region exhibits autofluorescence.

15. A system comprising:

a magnet configured to provide a magnetic field;

a switch configured to control application of the magnetic field to a fluorescent region of a sample;

a camera configured to image at least part of the fluorescent region in the presence of the magnetic field; and

a processor operably coupled to the camera and configured to:

determine a first relaxation time associated with a decay of the fluorescence of the at least part of the fluorescent region in an absence of the magnetic field,

determine a second relaxation time associated with a decay of the fluorescence of the at least part of the fluorescent region in the presence of the magnetic field,

perform a comparison of the first relaxation time to the second relaxation time to determine a difference between the first relaxation time and the second relaxation time, and

identify the at least part of the fluorescent region based on the difference between the first relaxation time and the second relaxation time.

16. The system of claim 15 wherein the magnet is further configured to provide the magnetic field at a strength of about 35 mT to about 100 mT.

17. The system of claim 15 wherein the switch is further configured to vary an orientation of the magnetic field with respect to the fluorescent region.

18. The system of claim 15 , wherein, to determine the first relaxation time, the processor is configured to obtain a first series of images of the at least part of the fluorescent region, and wherein, to determine the second relaxation time, the processor is configured to obtain a second series of images of the at least part of the fluorescent region.

19. The system of claim 18 , wherein the processor is further configured to:

determine a change in a first fluorescence spectrum associated with the at least part of the fluorescent region from the first series of images;

determine a change in a second fluorescence spectrum associated with the at least part of the fluorescent region from the second series of images; and

wherein to perform the comparison of the first relaxation time to the second relaxation time, the processor is configured to compare the change in the first fluorescence spectrum to the change in the second fluorescence spectrum.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2019
From: CRESTLINE DIRECT FINANCE, L.P.
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 049924/0794 →
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2016
From: RAJA, SUFI OASIM; DASGUPTA, ANJAN KR.
To: UNIVERSITY OF CALCUTTA
Reel/Frame 038860/0244 →